nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—AR—duct of salivary gland—salivary gland cancer	0.243	0.61	CbGeAlD
Fluoxymesterone—SHBG—neck—salivary gland cancer	0.0192	0.0483	CbGeAlD
Fluoxymesterone—SHBG—connective tissue—salivary gland cancer	0.0138	0.0346	CbGeAlD
Fluoxymesterone—ESR1—neck—salivary gland cancer	0.0135	0.034	CbGeAlD
Fluoxymesterone—NR3C1—neck—salivary gland cancer	0.00998	0.0251	CbGeAlD
Fluoxymesterone—AR—connective tissue—salivary gland cancer	0.00988	0.0248	CbGeAlD
Fluoxymesterone—ESR1—connective tissue—salivary gland cancer	0.0097	0.0244	CbGeAlD
Fluoxymesterone—AR—epithelium—salivary gland cancer	0.00938	0.0236	CbGeAlD
Fluoxymesterone—ESR1—epithelium—salivary gland cancer	0.00921	0.0232	CbGeAlD
Fluoxymesterone—NR3C1—parotid gland—salivary gland cancer	0.00813	0.0204	CbGeAlD
Fluoxymesterone—NR3C1—saliva-secreting gland—salivary gland cancer	0.00779	0.0196	CbGeAlD
Fluoxymesterone—AR—lymphoid tissue—salivary gland cancer	0.00722	0.0182	CbGeAlD
Fluoxymesterone—NR3C1—connective tissue—salivary gland cancer	0.00716	0.018	CbGeAlD
Fluoxymesterone—ESR1—lymphoid tissue—salivary gland cancer	0.00709	0.0178	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—salivary gland cancer	0.00679	0.0171	CbGeAlD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SMARCA2—salivary gland cancer	0.00676	0.0112	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00668	0.0111	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—PIK3CA—salivary gland cancer	0.00661	0.011	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CRTC1—salivary gland cancer	0.00646	0.0107	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NUP62—salivary gland cancer	0.00641	0.0106	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CRTC1—salivary gland cancer	0.00636	0.0106	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SMARCE1—salivary gland cancer	0.00633	0.0105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—salivary gland cancer	0.00603	0.01	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—NUP62—salivary gland cancer	0.00595	0.00988	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—MAML2—salivary gland cancer	0.0059	0.0098	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—NUP62—salivary gland cancer	0.00586	0.00973	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—PRKDC—salivary gland cancer	0.00578	0.0096	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—PIK3CA—salivary gland cancer	0.00574	0.00953	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—salivary gland cancer	0.00561	0.00931	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00546	0.00906	CbGpPWpGaD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K2—salivary gland cancer	0.00533	0.00884	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—HRAS—salivary gland cancer	0.00531	0.00881	CbGpPWpGaD
Fluoxymesterone—NR3C1—lymphoid tissue—salivary gland cancer	0.00523	0.0132	CbGeAlD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.0052	0.00864	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—PIK3CA—salivary gland cancer	0.00482	0.008	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—MAP2K2—salivary gland cancer	0.00475	0.00788	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—BRCA1—salivary gland cancer	0.00455	0.00756	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—VCAN—salivary gland cancer	0.00423	0.00702	CbGpPWpGaD
Fluoxymesterone—AR—lymph node—salivary gland cancer	0.00408	0.0102	CbGeAlD
Fluoxymesterone—NR3C1—Adipogenesis—WNT5B—salivary gland cancer	0.00402	0.00667	CbGpPWpGaD
Fluoxymesterone—ESR1—lymph node—salivary gland cancer	0.004	0.0101	CbGeAlD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYB—salivary gland cancer	0.00384	0.00638	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ZIM2—salivary gland cancer	0.00382	0.00635	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYB—salivary gland cancer	0.00378	0.00628	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00372	0.00618	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—BRCA1—salivary gland cancer	0.00351	0.00582	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—BRCA1—salivary gland cancer	0.0035	0.00582	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—MAP2K2—salivary gland cancer	0.00335	0.00556	CbGpPWpGaD
Fluoxymesterone—NR3C1—lymph node—salivary gland cancer	0.00295	0.00742	CbGeAlD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ZIM2—salivary gland cancer	0.00294	0.00489	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ZIM2—salivary gland cancer	0.0029	0.00481	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PTEN—salivary gland cancer	0.0029	0.00481	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—NOTCH1—salivary gland cancer	0.00279	0.00463	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—BRCA1—salivary gland cancer	0.00277	0.0046	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.0027	0.00448	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—CREBBP—salivary gland cancer	0.00266	0.00442	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—DTX4—salivary gland cancer	0.00264	0.00439	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00263	0.00436	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—BRCA1—salivary gland cancer	0.0026	0.00431	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—BRCA1—salivary gland cancer	0.00259	0.0043	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CREBBP—salivary gland cancer	0.00253	0.0042	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—WNT5B—salivary gland cancer	0.00248	0.00412	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL17RD—salivary gland cancer	0.0024	0.00398	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CYLD—salivary gland cancer	0.00239	0.00397	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—salivary gland cancer	0.00232	0.00385	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—CREBBP—salivary gland cancer	0.0023	0.00381	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PRKDC—salivary gland cancer	0.00229	0.0038	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAML3—salivary gland cancer	0.00219	0.00364	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGF16—salivary gland cancer	0.00218	0.00363	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CREBBP—salivary gland cancer	0.00213	0.00354	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NUP62—salivary gland cancer	0.00209	0.00348	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.00208	0.00345	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—CREBBP—salivary gland cancer	0.00205	0.00341	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGF16—salivary gland cancer	0.00205	0.0034	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.00205	0.0034	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.00204	0.00339	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00199	0.00331	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MC3R—salivary gland cancer	0.00195	0.00324	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—salivary gland cancer	0.00189	0.00314	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00188	0.00312	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ZIM2—salivary gland cancer	0.00184	0.00305	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—EP300—salivary gland cancer	0.00181	0.00301	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAP2K2—salivary gland cancer	0.0018	0.00299	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—PIK3CA—salivary gland cancer	0.00178	0.00295	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00176	0.00292	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—CREBBP—salivary gland cancer	0.00174	0.00289	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—PIK3CA—salivary gland cancer	0.00174	0.00288	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—EP300—salivary gland cancer	0.00172	0.00286	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DTX4—salivary gland cancer	0.00171	0.00284	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00171	0.00283	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.0017	0.00282	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—CREBBP—salivary gland cancer	0.00169	0.00281	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—ATM—salivary gland cancer	0.00167	0.00277	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—salivary gland cancer	0.00164	0.00273	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—salivary gland cancer	0.00164	0.00272	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00164	0.00271	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGFR4—salivary gland cancer	0.00161	0.00268	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FBXW7—salivary gland cancer	0.00159	0.00264	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—salivary gland cancer	0.00158	0.00263	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCND1—salivary gland cancer	0.00158	0.00262	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—NOTCH1—salivary gland cancer	0.00157	0.00261	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—UHRF1—salivary gland cancer	0.00156	0.0026	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.00156	0.0026	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—salivary gland cancer	0.00152	0.00252	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CREBBP—salivary gland cancer	0.00152	0.00252	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGFR4—salivary gland cancer	0.00151	0.00251	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—EP300—salivary gland cancer	0.00145	0.00241	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ZIM2—salivary gland cancer	0.00142	0.00235	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGF16—salivary gland cancer	0.00141	0.00235	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00141	0.00233	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—EP300—salivary gland cancer	0.0014	0.00232	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ZIM2—salivary gland cancer	0.0014	0.00232	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00136	0.00225	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00135	0.00224	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FOXO3—salivary gland cancer	0.00134	0.00222	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00131	0.00218	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00131	0.00217	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.0013	0.00215	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00126	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00126	0.00208	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.00125	0.00208	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00124	0.00206	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—salivary gland cancer	0.00123	0.00204	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAML2—salivary gland cancer	0.00123	0.00204	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.00122	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—UHRF1—salivary gland cancer	0.00121	0.002	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.0012	0.00199	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.0012	0.00199	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—UHRF1—salivary gland cancer	0.00119	0.00197	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.00119	0.00197	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NFIB—salivary gland cancer	0.00119	0.00197	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ARID4B—salivary gland cancer	0.00119	0.00197	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.00116	0.00192	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—salivary gland cancer	0.00115	0.00191	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.00114	0.0019	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.00113	0.00187	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.00112	0.00187	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—salivary gland cancer	0.00112	0.00186	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.00111	0.00185	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00111	0.00184	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—salivary gland cancer	0.00109	0.00182	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAP2K2—salivary gland cancer	0.00109	0.00182	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00108	0.0018	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PTEN—salivary gland cancer	0.00108	0.0018	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—salivary gland cancer	0.00107	0.00178	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JAG1—salivary gland cancer	0.00105	0.00174	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00105	0.00174	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGFR4—salivary gland cancer	0.00104	0.00173	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.00104	0.00172	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—salivary gland cancer	0.00103	0.00171	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00103	0.00171	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FBXW7—salivary gland cancer	0.00103	0.0017	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00102	0.0017	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—salivary gland cancer	0.00102	0.00169	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—salivary gland cancer	0.00101	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00101	0.00168	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.000996	0.00165	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—salivary gland cancer	0.000991	0.00165	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.000986	0.00164	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000968	0.00161	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—salivary gland cancer	0.000964	0.0016	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000955	0.00159	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—salivary gland cancer	0.000949	0.00158	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000947	0.00157	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.000923	0.00153	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NFIB—salivary gland cancer	0.000913	0.00152	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ARID4B—salivary gland cancer	0.000913	0.00152	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NFIB—salivary gland cancer	0.0009	0.00149	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ARID4B—salivary gland cancer	0.0009	0.00149	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.000881	0.00146	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FOXO3—salivary gland cancer	0.000866	0.00144	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.000858	0.00142	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.000845	0.0014	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—salivary gland cancer	0.000837	0.00139	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000823	0.00137	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAML3—salivary gland cancer	0.000822	0.00136	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CREBBP—salivary gland cancer	0.000812	0.00135	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDH1—salivary gland cancer	0.000806	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00076	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000736	0.00122	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000735	0.00122	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000734	0.00122	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00073	0.00121	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000725	0.0012	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000709	0.00118	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000707	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.000698	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—salivary gland cancer	0.00069	0.00115	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—salivary gland cancer	0.000679	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000677	0.00112	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000659	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000634	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAML3—salivary gland cancer	0.000633	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—salivary gland cancer	0.000624	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAML3—salivary gland cancer	0.000623	0.00104	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000609	0.00101	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—salivary gland cancer	0.000599	0.000994	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000588	0.000976	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—salivary gland cancer	0.00058	0.000963	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—salivary gland cancer	0.000579	0.000962	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000566	0.00094	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000561	0.000931	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EP300—salivary gland cancer	0.000553	0.000919	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000547	0.000907	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—salivary gland cancer	0.000544	0.000903	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CREBBP—salivary gland cancer	0.000525	0.000872	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000521	0.000865	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NUP62—salivary gland cancer	0.000508	0.000843	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.0005	0.00083	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000484	0.000804	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000469	0.000779	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT5B—salivary gland cancer	0.000466	0.000774	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAML2—salivary gland cancer	0.00046	0.000764	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000453	0.000752	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000451	0.000749	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL17RD—salivary gland cancer	0.00045	0.000747	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000432	0.000717	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SMC1A—salivary gland cancer	0.000425	0.000706	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000415	0.000689	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAML3—salivary gland cancer	0.000412	0.000683	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—salivary gland cancer	0.000409	0.000679	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000409	0.000679	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000401	0.000666	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NUP62—salivary gland cancer	0.000391	0.000649	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—salivary gland cancer	0.000389	0.000645	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NUP62—salivary gland cancer	0.000385	0.00064	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000384	0.000637	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—salivary gland cancer	0.000379	0.000629	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—salivary gland cancer	0.000375	0.000623	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000373	0.000619	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MC3R—salivary gland cancer	0.000367	0.000609	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—salivary gland cancer	0.000358	0.000594	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—salivary gland cancer	0.000355	0.000589	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAML2—salivary gland cancer	0.000354	0.000588	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000353	0.000586	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAML2—salivary gland cancer	0.000349	0.000579	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000347	0.000577	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000342	0.000568	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SMC1A—salivary gland cancer	0.000327	0.000544	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SMC1A—salivary gland cancer	0.000322	0.000535	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DTX4—salivary gland cancer	0.000321	0.000532	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000319	0.00053	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000315	0.000523	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.00031	0.000515	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000309	0.000513	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF16—salivary gland cancer	0.000265	0.00044	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—salivary gland cancer	0.000265	0.000439	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—salivary gland cancer	0.000256	0.000425	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—salivary gland cancer	0.000245	0.000406	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAML2—salivary gland cancer	0.00023	0.000383	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—salivary gland cancer	0.000217	0.000361	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CREBBP—salivary gland cancer	0.000197	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JAG1—salivary gland cancer	0.000197	0.000327	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR4—salivary gland cancer	0.000196	0.000325	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FBXW7—salivary gland cancer	0.000193	0.00032	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—salivary gland cancer	0.000167	0.000278	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—salivary gland cancer	0.000165	0.000274	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO3—salivary gland cancer	0.000163	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CREBBP—salivary gland cancer	0.000152	0.000252	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CREBBP—salivary gland cancer	0.000149	0.000248	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000133	0.00022	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000109	0.000181	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREBBP—salivary gland cancer	9.86e-05	0.000164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—salivary gland cancer	7.3e-05	0.000121	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—salivary gland cancer	7.04e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—salivary gland cancer	6.72e-05	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—salivary gland cancer	4.97e-05	8.25e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—salivary gland cancer	4.81e-05	7.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—salivary gland cancer	4.6e-05	7.63e-05	CbGpPWpGaD
